Endocrinology, Diabetes News | Endocrine Treatment & Research
WEBA free diabetes, endocrinology and medical news article resource for endocrinologists and physicians. Endocrinology conference coverage and drug information.
Type 2 Diabetes Medications That Induce Weight Loss
WEBMar 22, 2024 · A weight loss of 5% to 15% can improve obesity-related complications. 1,2. There are approved medications to help treat obesity, including phentermine (Lomaira®), orlistat (Alli®), topiramate (Trokendi XR®), and naltrexone/bupropion (Contrave®). However, these are not indicated to treat type 2 diabetes. 3.
Thyroid Hormone Resistance - Endocrinology Advisor
WEBNov 17, 2022 · Thyroid hormone resistance (THR) describes a syndrome that causes impaired sensitivity to thyroid hormones, which exert a key role in postembryonic development and physiological homeostasis. Thyroid hormone resistance is a rare condition that has often been misdiagnosed and mistreated. Because there is no therapy currently shown to completely ...
Central Hypothyroidism - Endocrinology Advisor
WEBNov 17, 2022 · Central hypothyroidism symptoms include 1,2: intolerance to cold and decreased sweating. dry skin and hair. fatigue, drowsiness, and headache. constipation. muscle cramps. changes in sleep and menstrual cycles. unexplained weight gain, along with swelling or puffiness. anxiety, depression, or memory loss.
How Do GLP-1 Receptor Agonists, Like Ozempic or Mounjaro, Work?
WEBJun 14, 2024 · GLP-1 receptor agonists also bind to the GLP-1 receptors on certain neurons in the brain to decrease hunger and increase satiety. They have been shown to slow gastric emptying within the first hour of eating, resulting in the feeling of being full. Patients who use GLP-1 receptor agonists experience reduced appetite and hunger, lower preference ...
Pheochromocytoma - Endocrinology Advisor
WEBNov 17, 2022 · Pheochromocytoma is a rare neuroendocrine disorder in which a tumor grows from chromaffin cells within the adrenal medulla of the adrenal glands. 1 This tumor causes the continuous overproduction of epinephrine and norepinephrine, which, if left without pheochromocytoma treatment, can lead to …
Sellar Mass - Endocrinology Advisor
WEBSellar masses (SMs) are adenoma bodies that are typically located on or around the pituitary gland, specifically near the sella turcica. 1,2 Sellar masses are known to account for approximately 10% to 15% of all intracranial neoplasms. 3,4 and are responsible for a myriad of visual, neurological, and hormonal deficiencies. 3 Pituitary adenomas ...
Acetaminophen Interference With Blood Glucose Readings: What …
WEBJun 12, 2017 · Clinicians managing blood glucose levels in critically ill children should take caution to ensure they are not treating false elevations of blood glucose caused by medication interference, according to research presented at the American Diabetes Association (ADA) 77th Scientific Sessions, held June 9-13 in San Diego, California.. Researchers from Boston, Massachusetts, and Philadelphia ...
Addison's Disease: New Guideline Details Diagnosis and Treatment
WEBFeb 5, 2016 · The Endocrine Society has issued its first ever clinical practice guideline on the diagnosis and treatment of primary adrenal insufficiency — a life-threatening endocrine disorder characterized by the insufficient production of glucocorticoids and/or mineralocorticoids by the adrenal cortex. Commonly known as …
Hypercalcemia - Endocrinology Advisor
WEBNov 17, 2022 · Hypercalcemia Causes & Presentation. Hypercalcemia is a condition in which the calcium level in your blood is above normal. The normal range of calcium is 8.5 to 10.5 mg/dl (4.3 to 5.3 mEq/L or 2.2 to 2.7 mmol/L). 1 This reference range may differ by 0.5 mg/dl depending on the laboratory or hypercalcemia workup. Patients typically present with symptoms of hypercalcemia when the serum calcium ...